Indivior Board Declares $8.13 Special Dividend Contingent on Supernus Merger Closing
INDV sits 60% above its 52-week low of $22.22.
Summary
Indivior's board declared an $8.13 per share special cash dividend, payable after the Supernus merger closes, with record date October 30, 2026 and payment expected November 6, 2026.
Key Events · Financing and Capital Events · INDV
-
Special Dividend Declared
Board declared $8.13 per share special cash dividend to holders of record on October 30, 2026, contingent on closing of the Supernus merger.
-
Payment Timeline
Merger expected to close November 2, 2026; dividend payment anticipated on or about November 6, 2026 to eligible record holders.
-
Tax Treatment
Majority of dividend expected to exceed current and accumulated earnings and profits, treated as return of capital to extent of basis, then capital gain.
-
Equity Award Holders Included
$8.13 per share also payable upon vesting to holders of certain Indivior equity awards outstanding as of the record date.
Analysis · INDV · Life Sciences
Indivior's board formalized the $8.13 per share special cash dividend tied to the pending Supernus merger. The dividend is contingent on the merger closing, expected November 2, 2026, with payment to record holders on or about November 6, 2026. The filing adds key administrative details: record date of October 30, 2026, and tax treatment indicating the majority of the dividend will be treated as return of capital rather than ordinary income. This is a significant capital return event for Indivior shareholders, though it remains contingent on shareholder approval of the merger at the October 15, 2026 vote.
How filings like this one have moved
In the 30 days to Sep 17, 2026, 29.7% of the 1739 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.34%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, INDV was trading at $35.51 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.1B. The 52-week trading range was $22.22 to $42.81. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.